niacin and acipimox
niacin has been researched along with acipimox in 16 studies
Research
Studies (16)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Amin, D; Bailey, K; Chakraborty, U; Musser, JH; Sciortino, S; Sutherland, CA; Whyzmuzis, C | 1 |
| Barnes, AA; Brown, AJ; Dowell, SJ; Eilert, M; Elshourbagy, N; Foord, SM; Fraser, NJ; Green, A; Hassall, DG; Ignar, DM; Marshall, FH; Murdock, PR; Pike, NB; Steplewski, K; Szekeres, PG; Wilson, S; Wise, A | 1 |
| Furuichi, K; Hiyama, H; Kamohara, M; Matsumoto, S; Matsuo, A; Matsushime, H; Ohishi, T; Saito, T; Soga, T; Takasaki, J | 1 |
| Boatman, PD; Chen, R; Connolly, DT; Decaire, M; Duong, T; Gharbaoui, T; Johnson, BR; Jung, JK; Richman, JG; Sage, CR; Semple, G; Uy, J | 1 |
| Nicholls, DP; O'Kane, MJ; Trimble, ER; Trinick, TR; Tynan, MB | 1 |
| Tornvall, P; Walldius, G | 1 |
| Aktories, K; Jakobs, KH; Schultz, G | 1 |
| Knight, BL; O'Connor, B; O'Donnell, M; Perombelon, N; Reaveley, D; Seed, M | 1 |
| Groop, L; Saloranta, C | 1 |
| Beck-Nielsen, H; Henriksen, JE; Vaag, A; Vinten, J; Worm, D | 1 |
| Andrianov, V; Kalvinsh, I; Lang, H; Lorenzen, A; Schwabe, U; Stannek, C | 1 |
| Casanueva, FF; Cordido, F; Dieguez, C; Martinez, T; Peñalva, A | 1 |
| Guo, W; Han, J; Wang-Fisher, YL | 1 |
| Ijzerman, AP; Soudijn, W; van Wijngaarden, I | 1 |
| Chai, J; Choudhury, RP; Digby, JE; Greaves, DR; Jefferson, A; Martinez, F; Ruparelia, N; Wamil, M | 1 |
| Sekhar, RV | 1 |
Reviews
3 review(s) available for niacin and acipimox
| Article | Year |
|---|---|
Interactions between glucose and FFA metabolism in man.
Topics: Animals; Biological Transport; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipolysis; Models, Biological; Niacin; Obesity; Pyrazines | 1996 |
Nicotinic acid receptor subtypes and their ligands.
Topics: Adipocytes; Amino Acid Sequence; Animals; Humans; Ligands; Lipolysis; Molecular Sequence Data; Niacin; Nicotinic Agonists; Pyrazines; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Sequence Alignment; Tissue Distribution | 2007 |
Treatment of dyslipidemia in HIV.
Topics: Anti-HIV Agents; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Diet Therapy; Dyslipidemias; Exercise Therapy; Ezetimibe; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Fibric Acids; Glutathione; Growth Hormone-Releasing Hormone; HIV Infections; Human Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leptin; Niacin; Pyrazines; Thiazolidinediones; Triglycerides | 2015 |
Trials
5 trial(s) available for niacin and acipimox
| Article | Year |
|---|---|
A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia.
Topics: Adult; Aged; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Pyrazines | 1992 |
A comparison between nicotinic acid and acipimox in hypertriglyceridaemia--effects on serum lipids, lipoproteins, glucose tolerance and tolerability.
Topics: Adult; Blood Glucose; Female; Glucose Tolerance Test; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Pyrazines | 1991 |
The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Niacin; Pyrazines; Triglycerides | 1993 |
The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients.
Topics: Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Female; Humans; Hypolipidemic Agents; Insulin; Leptin; Male; Middle Aged; Niacin; Pyrazines; Triglycerides | 2000 |
Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
Topics: Acromegaly; Adenoma; Area Under Curve; Fatty Acids, Nonesterified; Feedback; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Niacin; Pituitary Neoplasms; Pyrazines; Statistics, Nonparametric | 2001 |
Other Studies
8 other study(ies) available for niacin and acipimox
| Article | Year |
|---|---|
Synthesis and antilipolytic activities of quinolyl carbanilates and related analogues.
Topics: Adipose Tissue; Aminoquinolines; Animals; Carbamates; Hypolipidemic Agents; Indicators and Reagents; Lipase; Lipolysis; Male; Myocardium; Rats; Structure-Activity Relationship | 1987 |
Molecular identification of high and low affinity receptors for nicotinic acid.
Topics: Amino Acid Sequence; Animals; Cell Membrane; CHO Cells; Cricetinae; Databases as Topic; DNA, Complementary; Dose-Response Relationship, Drug; Female; Furans; Humans; Hyperlipidemias; Hypolipidemic Agents; Inhibitory Concentration 50; Male; Molecular Sequence Data; Niacin; Oocytes; Protein Binding; Pyrazines; Rats; Receptors, Nicotinic; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution; Xenopus | 2003 |
Molecular identification of nicotinic acid receptor.
Topics: Adipocytes; Amino Acid Sequence; Animals; Cell Line; Cloning, Molecular; Colforsin; Cyclic AMP; DNA, Complementary; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Mice; Molecular Sequence Data; Niacin; Open Reading Frames; Poly A; Pyrazines; Radioligand Assay; Rats; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution | 2003 |
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
Topics: Cell Line; Cyclic AMP; Furans; Humans; Niacin; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2007 |
Inhibition of adenylate cyclase and stimulation of a high affinity GTPase by the antilipolytic agents, nicotinic acid, acipimox and various related compounds.
Topics: Adenylyl Cyclase Inhibitors; Adipose Tissue; Animals; Cricetinae; Epididymis; GTP Phosphohydrolases; Hypolipidemic Agents; In Vitro Techniques; Male; Niacin; Phosphoric Monoester Hydrolases; Pyrazines | 1983 |
Characterization of a G protein-coupled receptor for nicotinic acid.
Topics: Adenylyl Cyclase Inhibitors; Adipocytes; Animals; Binding Sites; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hypolipidemic Agents; In Vitro Techniques; Male; Niacin; Pyrazines; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Nicotinic; Spleen; Structure-Activity Relationship; Sulfur Radioisotopes; Tritium | 2001 |
Acipimox stimulates leptin production from isolated rat adipocytes.
Topics: Adipocytes; Animals; Bucladesine; Cells, Cultured; Female; Glycerol; Hypolipidemic Agents; Insulin; Leptin; Lipolysis; Niacin; Norepinephrine; Pyrazines; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 2002 |
Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms.
Topics: Anti-Inflammatory Agents; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Chemotaxis, Leukocyte; Cyclooxygenase 2 Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation; Inflammation Mediators; Integrin alpha4beta1; Interleukin-6; Lipopolysaccharides; Monocytes; Niacin; Phosphorylation; Pyrazines; Receptors, G-Protein-Coupled; Receptors, Immunologic; Receptors, Nicotinic; Receptors, Prostaglandin; RNA Interference; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA; Transfection; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2012 |